Ginès, Pere.
Pere Ginès researcher
Ginès i Gibert, Pere
VIAF ID: 86958196 (Personal)
Permalink: http://viaf.org/viaf/86958196
Preferred Forms
- 100 1 _ ‡a Ginès, Pere
-
- 100 1 _ ‡a Ginès, Pere
-
- 100 1 _ ‡a Ginès, Pere
-
- 100 1 _ ‡a Ginès i Gibert, Pere
- 100 1 _ ‡a Ginès, Pere
-
-
-
-
- 100 0 _ ‡a Pere Ginès ‡c researcher
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
Ascites and renal dysfunction in liver disease : pathogenesis, diagnosis, and treatment | |
Autotest: gastroenterología y hepatología | |
Avaluació d'un programa d'infermeria d'atenció immediata a persones amb problemes de salut aguts lleus | |
Chronic liver failure mechanisms and management | |
Cirrosi hepàtica descompensada : impacte global de la síndrome de insuficiència hepàtica aguda sobre crònica i avaluació d’un nou biomarcador pronòstic | |
Contribució a l'estudi de la hiponatrèmia a la cirrosi hepàtica : descripció d'una nova causa i implicacions sobre la qualitat de vida dels pacients | |
Efecte de l'administració de seroalbúmina en el deteriorament de la funció renal i la mortalitat dels pacients amb peritonitis bacteriana espontània | |
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium | |
Estudio de los microRNAs en la fisiopatología de la hepatitis alcohólica | |
Expresión Génica Hepática en pacientes con hepatopatías crónicas : identificacación de dianas terapéuticas y evaluación de un tratamiento antifibrogénico | |
Generació de cèl·lules estrellades derivades de iPSCs i la seva utilització com a model per l'estudi de la fibrosi hepàtica | |
Hepatitis alcohólica[Recurs electrònic] : estratificación pronóstica e identificación de mecanismos patogénicos | |
Insuficiencia renal en la cirrosis : evaluación de nuevas clasificaciones pronósticas y tratamiento del síndrome hepato-renal tipo 1 asociado a sepsis | |
Investigació de les bases cel·lulars i moleculars de la fibrosi hepàtica : paper dels sistemes vasoactius | |
Investigación de la función contráctil de las células estrelladas hepáticas: regulación por vasoconstrictores | |
Investigación del papel de la hiponatremia como factor de riesgo de encefalopatía hepática en la cirrosis | |
A new scoring system for prognostic stratification of patients with alcoholic hepatitis | |
[New therapeutic strategies in liver fibrosis: pathogenic basis] | |
Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. | |
Official congress report Autoimmune diseases of the liver Falk Symposium 197, Lisbon, May 8-9, 2015 | |
[Pancreatic ascites. Study of 3 cases and review of the literature] | |
La paracentesi en el tractament dels malalts cirròtics amb ascites | |
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy. | |
Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury. | |
Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis | |
[Physiopathology of ascites in cirrhosis. A multidisciplinary problem] | |
Portal hypertension | |
Postępy w chorobach wewnętrznych / Christian Mueller [i inni] // MP Medycyna Praktyczna. - 10 (368) 2021, strony 8-18. | |
Postępy w chorobach wewnętrznych - najważniejsze dokonania ostatnich lat : opinie ekspertów MIRCIM. | |
Practical recommendations for the treatment of ascites and its complications | |
PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology | |
Predicting mortality in cirrhosis--serum sodium helps | |
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study | |
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA | |
Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study | |
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis | |
Prognostic significance of renal dysfunction in cirrhosis. | |
Prognostic value and treatment of hyponatremia in patients with advanced cirrhosis and acute on chronic liver failure | |
Refractory ascites: definition and mechanism | |
Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. | |
Renal effects of amino acid administration in cirrhosis | |
Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis | |
Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis | |
Reply to: "Acute-on-chronic liver failure - its definition remains unclear". | |
Reply to: "To close the stable door before the horse has bolted". | |
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. | |
Review article: albumin for circulatory support in patients with cirrhosis. | |
[Role of albumin in the treatment of hepatorenal syndrome in cirrhosis] | |
Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development. | |
Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients. | |
Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. | |
Therapy in liver diseases | |
Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial | |
Therapy with vasoconstrictor drugs in cirrhosis: The time has arrived | |
[Thrombocytopenic purpura and acute nephropathy associated with circulating immune complexes in hepatitis A virus infection] | |
TIPS and refractory ascites. Lessons from the recent history of ascites therapy | |
Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study | |
Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis | |
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems | |
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis | |
Trastorn circulatori postparacentesi incidència, implicacions pronòstiques i prevenció amb expansors plasmàtics | |
Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. | |
Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats | |
Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites | |
Urinary excretion of endogenous digitalis-like natriuretic substances in healthy subjects. Effect of sodium load. | |
Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. | |
Utilidad del MELD y el sodio pretrasplante en el pronóstico del trasplante hepático a corto plazo | |
Valoración de la Función Ventricular Izquierda en la Cirrosis Hepática: Relación con la Hemodinámica Sistémica y la Disfunción Renal | |
Vaptans: a promising therapy in the management of advanced cirrhosis. | |
Vasopressin in pathophysiological states. | |
What's new in the treatment of ascites and spontaneous bacterial peritonitis. |